$EG
EVEREST GROUP, LTD. Stock $eg

$eg Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000109507321000017 Filed on May 10, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$260.4M	$1.982B
YoY Change	-86.86%	0.82%
Cost Of Revenue		$1.431B
YoY Change		36.46%
Gross Profit		$551.2M
YoY Change		-39.91%
Gross Profit Margin		27.81%
Selling, General & Admin	$501.4M	$458.4M
YoY Change	9.38%	15.73%
% of Gross Profit		83.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.355B	$1.868B
YoY Change	26.06%	21.01%
Operating Profit		-$1.317B
YoY Change		110.23%
Interest Expense	-$15.60M	$7.583M
YoY Change	-305.72%	-0.63%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$373.1M	-$43.62M
YoY Change	-955.29%	-110.52%
Income Tax	$31.20M	-$60.23M
% Of Pretax Income	8.36%
Net Earnings	$341.9M	$16.61M
YoY Change	1957.92%	-95.31%
Net Earnings / Revenue	131.28%	0.84%
Basic Earnings Per Share	$8.53	$0.41
Diluted Earnings Per Share	$8.52	$0.41
COMMON SHARES
Basic Shares Outstanding	39.54M shares	40.20M shares
Diluted Shares Outstanding	39.60M shares	40.30M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.133B	$817.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment		$157.0M
YoY Change		124.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.173B	$1.804B
YoY Change	20.48%	9.72%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$33.60B	$27.22B
YoY Change	23.41%	6.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$24.00M	$175.0M
YoY Change	-86.29%	105.88%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$50.00M
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$175.0M	$302.0M
YoY Change	-42.05%	54.08%
LONG-TERM LIABILITIES
Long-Term Debt	$1.911B	$632.0M
YoY Change	202.37%	-0.32%
Other Long-Term Liabilities	$578.0M	$291.0M
YoY Change	98.63%	148.72%
Total Long-Term Liabilities	$2.489B	$923.0M
YoY Change	169.66%	22.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$175.0M	$302.0M
Total Long-Term Liabilities	$2.489B	$923.0M
Total Liabilities	$23.91B	$18.64B
YoY Change	28.27%	8.36%
SHAREHOLDERS EQUITY
Retained Earnings	$10.85B	$10.26B
YoY Change	5.77%	4.34%
Common Stock	$698.0K	$696.0K
YoY Change	0.29%	0.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.646B	$3.622B
YoY Change	0.65%	6.11%
Treasury Stock Shares	29.73M shares	29.64M shares
Shareholders Equity	$9.683B	$8.581B
YoY Change
Total Liabilities & Shareholders Equity	$33.60B	$27.22B
YoY Change	23.41%	6.37%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$341.9M	$16.61M
YoY Change	1957.92%	-95.31%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$904.4M	$506.0M
YoY Change	78.73%	10.04%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$455.5M	-$258.2M
YoY Change	76.41%	-40.34%
Cash From Investing Activities	-$455.5M	-$258.2M
YoY Change	76.43%	-40.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$23.55M	$200.0M
YoY Change	-88.23%	1138.28%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$108.9M	-$241.1M
YoY Change	-54.84%	159.14%
NET CHANGE
Cash From Operating Activities	$904.4M	$506.0M
Cash From Investing Activities	-$455.5M	-$258.2M
Cash From Financing Activities	-$108.9M	-$241.1M
Net Change In Cash	$331.0M	$9.590M
YoY Change	3351.61%	-113.3%
FREE CASH FLOW
Cash From Operating Activities	$904.4M	$506.0M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q1	re	Assumed Losses And Loss Adjustment Expenses AssumedLossesAndLossAdjustmentExpenses		USD
CY2020Q1	re	Assumed Losses And Loss Adjustment Expenses AssumedLossesAndLossAdjustmentExpenses		USD
CY2021Q1	re	Contractual Commitments Investment Period Expiration Date ContractualCommitmentsInvestmentPeriodExpirationDate	2026-12-31
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Seon Place – 4th Floor
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001095073
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt		USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease		USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal		USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	-320000	USD
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss		USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease		USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal		USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold		USD
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	1-15731
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	EVEREST RE GROUP, LTD.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0365432
CY2021Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	141 Front Street
CY2021Q1	dei	Entity Address Address Line3 EntityAddressAddressLine3	PO Box HM 845
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Hamilton
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	HM 19
CY2021Q1	dei	Entity Address Country EntityAddressCountry	BM
CY2021Q1	dei	City Area Code CityAreaCode	441
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	295-0006
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Security12b Title Security12bTitle	Common Shares, $0.01 par value
CY2021Q1	dei	Trading Symbol TradingSymbol	RE
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40083525	shares
CY2021Q1	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	20407480000	USD
CY2020Q4	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	20040173000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19932190000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	8723000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	1745000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1400674000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1472236000	USD
CY2021Q1	re	Other Short Term Investments Cost OtherShortTermInvestmentsCost	826777000	USD
CY2020Q4	re	Other Short Term Investments Cost OtherShortTermInvestmentsCost	1135088000	USD
CY2021Q1	us-gaap	Other Short Term Investments OtherShortTermInvestments	826769000	USD
CY2020Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	1134950000	USD
CY2021Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2173221000	USD
CY2020Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2012581000	USD
CY2021Q1	us-gaap	Equity Method Investments EquityMethodInvestments	2173221000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2012581000	USD
CY2021Q1	us-gaap	Cash Cash	1132660000	USD
CY2020Q4	us-gaap	Cash Cash	801651000	USD
CY2021Q1	us-gaap	Investments And Cash InvestmentsAndCash	25940804000	USD
CY2020Q4	us-gaap	Investments And Cash InvestmentsAndCash	25461591000	USD
CY2021Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	156330000	USD
CY2020Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	141304000	USD
CY2021Q1	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	2789602000	USD
CY2020Q4	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	2680562000	USD
CY2021Q1	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	2029734000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	1994555000	USD
CY2021Q1	us-gaap	Funds Held Under Reinsurance Agreements Asset FundsHeldUnderReinsuranceAgreementsAsset	740554000	USD
CY2020Q4	us-gaap	Funds Held Under Reinsurance Agreements Asset FundsHeldUnderReinsuranceAgreementsAsset	716655000	USD
CY2021Q1	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	663560000	USD
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	622053000	USD
CY2021Q1	us-gaap	Prepaid Reinsurance Premiums PrepaidReinsurancePremiums	441606000	USD
CY2020Q4	us-gaap	Prepaid Reinsurance Premiums PrepaidReinsurancePremiums	412015000	USD
CY2021Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	31738000	USD
CY2020Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	17253000	USD
CY2021Q1	us-gaap	Other Assets OtherAssets	801424000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	742369000	USD
CY2021Q1	us-gaap	Assets Assets	33595352000	USD
CY2020Q4	us-gaap	Assets Assets	32788357000	USD
CY2021Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	17090644000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	16398997000	USD
CY2021Q1	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	37561000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	37723000	USD
CY2021Q1	us-gaap	Unearned Premiums UnearnedPremiums	3704189000	USD
CY2020Q4	us-gaap	Unearned Premiums UnearnedPremiums	3501359000	USD
CY2021Q1	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	13875000	USD
CY2020Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	15807000	USD
CY2021Q1	us-gaap	Reinsurance Payable ReinsurancePayable	402379000	USD
CY2020Q4	us-gaap	Reinsurance Payable ReinsurancePayable	294347000	USD
CY2021Q1	re	Loss In Course Of Payment LossInCourseOfPayment	139382000	USD
CY2020Q4	re	Loss In Course Of Payment LossInCourseOfPayment	127971000	USD
CY2021Q1	us-gaap	Subordinated Debt SubordinatedDebt	223699000	USD
CY2020Q4	us-gaap	Subordinated Debt SubordinatedDebt	223674000	USD
CY2021Q1	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	310000000	USD
CY2020Q4	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	310000000	USD
CY2021Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	24035000	USD
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	10460000	USD
CY2021Q1	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	151174000	USD
CY2020Q4	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	206693000	USD
CY2021Q1	us-gaap	Other Liabilities OtherLiabilities	438654000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	558432000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	23912470000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	23062181000	USD
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69816000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69620000	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	698000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	696000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2245737000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2245301000	USD
CY2021Q1	re	Accumulated Other Comprehensive Income Loss Tax AccumulatedOtherComprehensiveIncomeLossTax	41161000	USD
CY2020	re	Accumulated Other Comprehensive Income Loss Tax AccumulatedOtherComprehensiveIncomeLossTax	80451000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	235079000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	534899000	USD
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	29734000	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	29636000	shares
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	3645717000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3622172000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	10847085000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	10567452000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	9682882000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9726176000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33595352000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32788357000	USD
CY2020Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	2036814000	USD
CY2020Q1	us-gaap	Net Investment Income NetInvestmentIncome	147800000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	-6977000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	-21774000	USD
CY2020Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-188814000	USD
CY2020Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-210588000	USD
CY2021Q1	us-gaap	Net Investment Income NetInvestmentIncome	260413000	USD
CY2021Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	2387865000	USD
CY2021Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	38902000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-299820000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	341862000	USD
CY2020Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	7990000	USD
CY2020Q1	us-gaap	Revenues Revenues	1982016000	USD
CY2020Q1	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	1430840000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	448522000	USD
CY2020Q1	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	128860000	USD
CY2020Q1	re	Corporate Expenses CorporateExpenses	9833000	USD
CY2021Q1	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	15639000	USD
CY2020Q1	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	7583000	USD
CY2020Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	2025638000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43622000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-60234000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	16612000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-31399000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-247999000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-50824000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-920000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-281291000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.55
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.55
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	9682882000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	8580944000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	16612000	USD
CY2021Q1	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	105460000	USD
CY2020Q1	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	119548000	USD
CY2021Q1	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	25584000	USD
CY2020Q1	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	28973000	USD
CY2021Q1	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	14518000	USD
CY2020Q1	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	130593000	USD
CY2021Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-24908000	USD
CY2020Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	65114000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Reinsurance Premiums IncreaseDecreaseInPrepaidReinsurancePremiums	27071000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Reinsurance Premiums IncreaseDecreaseInPrepaidReinsurancePremiums	10572000	USD
CY2021Q1	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	655054000	USD
CY2020Q1	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	406257000	USD
CY2021Q1	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-162000	USD
CY2020Q1	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-915000	USD
CY2021Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	196631000	USD
CY2020Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	158744000	USD
CY2021Q1	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	105390000	USD
CY2020Q1	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	95555000	USD
CY2021Q1	re	Increase Decrease In Losses In Course Of Payment IncreaseDecreaseInLossesInCourseOfPayment	11980000	USD
CY2020Q1	re	Increase Decrease In Losses In Course Of Payment IncreaseDecreaseInLossesInCourseOfPayment	-1422000	USD
CY2021Q1	re	Change In Equity Adjustments In Limited Partnerships ChangeInEquityAdjustmentsInLimitedPartnerships	116767000	USD
CY2020Q1	re	Change In Equity Adjustments In Limited Partnerships ChangeInEquityAdjustmentsInLimitedPartnerships	8512000	USD
CY2021Q1	us-gaap	Reimbursement From Limited Partnership Investment ReimbursementFromLimitedPartnershipInvestment	18125000	USD
CY2020Q1	us-gaap	Reimbursement From Limited Partnership Investment ReimbursementFromLimitedPartnershipInvestment	11108000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-279398000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-297903000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	149464000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	45259000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11021000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9393000	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	17323000	USD
CY2020Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	8640000	USD
CY2020Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-210588000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	904366000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	505989000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	818352000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	656070000	USD
CY2021Q1	re	Proceeds From Sale Of Available For Sale Securities Debt Market Value ProceedsFromSaleOfAvailableForSaleSecuritiesDebtMarketValue	228278000	USD
CY2020Q1	re	Proceeds From Sale Of Available For Sale Securities Debt Market Value ProceedsFromSaleOfAvailableForSaleSecuritiesDebtMarketValue	501953000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	281313000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	112841000	USD
CY2021Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	52211000	USD
CY2020Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	104085000	USD
CY2021Q1	re	Payments To Acquire Available For Sale Securities Debt Market Value PaymentsToAcquireAvailableForSaleSecuritiesDebtMarketValue	1776730000	USD
CY2020Q1	re	Payments To Acquire Available For Sale Securities Debt Market Value PaymentsToAcquireAvailableForSaleSecuritiesDebtMarketValue	1359281000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	174981000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	76513000	USD
CY2021Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	98939000	USD
CY2020Q1	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	152269000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-308585000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	27882000	USD
CY2021Q1	re	Net Change In Unsettled Securities Transactions NetChangeInUnsettledSecuritiesTransactions	93610000	USD
CY2020Q1	re	Net Change In Unsettled Securities Transactions NetChangeInUnsettledSecuritiesTransactions	17185000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-455521000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-258181000	USD
CY2021Q1	re	Payments For Shares Issued For Share Based Compensation Net Of Expense PaymentsForSharesIssuedForShareBasedCompensationNetOfExpense	10583000	USD
CY2020Q1	re	Payments For Shares Issued For Share Based Compensation Net Of Expense PaymentsForSharesIssuedForShareBasedCompensationNetOfExpense	12573000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	23545000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	200020000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	62229000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	63277000	USD
CY2020Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	50000000	USD
CY2020Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	1198000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	12507000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13982000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-108864000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-241050000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-8972000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2832000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	331009000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9590000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	801651000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	808036000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1132660000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	817626000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6417000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4920000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1880000	USD
CY2020Q1	us-gaap	Investment Income Net InvestmentIncomeNet	147800000	USD
CY2021Q1	re	Additional Contractual Commitments AdditionalContractualCommitments	1413543000	USD
CY2020Q1	us-gaap	Undistributed Earnings UndistributedEarnings	-46666000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	2817000	USD
CY2021Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-weight: bold; font-size: 10.00pt">1. GENERAL</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">Everest Re Group, Ltd. (“Group”), a Bermuda company, through its subsidiaries, principally provides reinsurance and insurance in the U.S., Bermuda and international markets. As used in this document, “Company” means Group and its subsidiaries.</span></p>
CY2021Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-weight: bold; font-size: 10.00pt">2. BASIS OF PRESENTATION</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">The unaudited consolidated financial statements of the Company as of March 31, 2021 and December 31, 2020 and for the three months ended March 31, 2021 and 2020 include all adjustments, consisting of normal recurring accruals, which, in the opinion of management, are necessary for a fair statement of the results on an interim basis. Certain financial information, which is normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), has been omitted since it is not required for interim reporting purposes. The December 31, 2020 consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The results for the three months ended March 31, 2021 and 2020 are not necessarily indicative of the results for a full year. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the years ended December 31, 2020, 2019 and 2018, included in the Company’s most recent Form 10-K filing.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">The Company consolidates the results of operations and financial position of all voting interest entities ("VOE") in which the Company has a controlling financial interest and all variable interest entities ("VIE") in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity. </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities (and disclosure of contingent assets and liabilities) at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Ultimate actual results could differ, possibly materially, from those estimates. This is particularly true given the fluid and continuing nature of the COVID-19 pandemic. This is an ongoing event and so is the Company’s evaluation and analysis. While the Company’s analysis considers all aspects of its operations, it does not take into account legal, regulatory or legislative intervention that could retroactively mandate or expand coverage provisions. Given the uncertainties in the current public health and economic environment, there could be an adverse impact on results for the Property & Casualty industry and the Company for the remainder of the year. The impact is dependent on the shape and length of the economic recovery.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">All intercompany accounts and transactions have been eliminated. </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt; text-decoration: underline">Application of Recently Issued Accounting Standard Changes. </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-style: italic; font-size: 10.00pt">Accounting for Income Taxes.</span><span style="font-family: Calibri; font-size: 10.00pt"> In December 2019, The Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, which provides simplification of existing guidance for income taxes, including the removal of certain exceptions related to recognition of deferred tax liabilities on foreign subsidiaries. The guidance is effective for annual reporting periods beginning after December 15, 2020 and interim periods within that annual reporting period. The Company adopted the guidance as of January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company’s financial statements.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-style: italic; font-size: 10.00pt">Accounting for Cloud Computing Arrangement. </span><span style="font-family: Calibri; font-size: 10.00pt">In August 2018, FASB issued ASU 2018-15, which outlines accounting for implementation costs of a cloud computing arrangement that is a service contract. This guidance requires that implementation costs of a cloud computing arrangement that is a service contract must be capitalized and expensed in accordance with the existing provisions provided in Subtopic 350-40 regarding development of internal use software. In addition, any capitalized implementation costs should be amortized over the term of the hosting arrangement. The guidance is effective for annual reporting periods beginning after December 15, 2019 and interim periods within that annual reporting period. The Company adopted the guidance as of January 1, 2020. The adoption of ASU 2018-15 did not have a material impact on the Company’s financial statements.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-style: italic; font-size: 10.00pt">Accounting for Long Duration Contracts.</span><span style="font-family: Calibri; font-size: 10.00pt"> In August 2018, FASB issued ASU 2018-12, which discusses changes to the recognition, measurement and presentation of long duration contracts. The main provisions of this guidance address the following: 1) In determining liability for future policy benefits, companies must review cash flow assumptions at least annually and the discount rate assumption at each reporting period date 2) Amortization of deferred acquisition costs has been simplified to be in constant level proportion to either premiums, gross profits or gross margins 3) Disaggregated roll forwards of beginning and ending liabilities for future policy benefits are required. The guidance was originally effective for annual reporting periods beginning after December 15, 2020 and interim periods within that annual reporting period. However, FASB issued ASU 2019-09 in November 2019 and then ASU 2020-11 in November 2021, which ultimately defers the effective date of ASU 2018-12 until annual reporting periods beginning after December 15, 2022. The Company is currently evaluating the impact of the adoption of ASU 2018-12 on its financial statements.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-style: italic; font-size: 10.00pt">Valuation of Financial Instruments. </span><span style="font-family: Calibri; font-size: 10.00pt">In June 2016, FASB issued ASU 2016-13 (and has subsequently issued related guidance and amendments in ASU 2019-11 and ASU 2019-10 in November 2019) which outline guidance on the valuation of and accounting for assets measured at amortized cost and available for sale debt securities. The new guidance requires the carrying value of assets measured at amortized cost, including reinsurance and premiums receivables to be presented as the net amount expected to be collected on the financial asset (amortized cost less an allowance for credit losses valuation account). The allowance reflects expected credit losses of the financial asset which considers available information using a combination both historical information, current market conditions and reasonable and supportable forecasts. For available-for-sale debt securities, the guidance modified the previous other than temporary impairment model, now requiring an allowance for estimated credit related losses rather than a permanent impairment, which will be limited to the amount by which fair value is below amortized cost. The guidance is effective for annual and interim reporting periods beginning after December 15, 2019. The Company adopted the guidance effective January 1, 2020, on a modified retrospective basis. The adoption resulted in a cumulative reduction of $</span><span style="font-family: Calibri; font-size: 10.00pt">4,214 thousand in retained earnings, net of tax, which is disclosed separately within the Consolidated Statements of Shareholders’ Equity.</span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt"> </span></p><p style="margin-bottom: 0; text-align: justify"><span style="font-family: Calibri; font-size: 10.00pt">Any issued guidance and pronouncements, other than those directly referenced above, are deemed by the Company to be either not applicable or immaterial to its financial statements.</span></p>
CY2021Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	19932190000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19932190000	USD
CY2021Q1	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	20407480000	USD
CY2020Q4	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	20040173000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-332708000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-277023000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-40427000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-29024000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-247999000	USD
CY2021Q1	re	Gross Investment Income Before Adjustment GrossInvestmentIncomeBeforeAdjustment	266286000	USD
CY2020Q1	re	Gross Investment Income Before Adjustment GrossInvestmentIncomeBeforeAdjustment	152117000	USD
CY2021Q1	re	Funds Held Interest Income Expense FundsHeldInterestIncomeExpense	7966000	USD
CY2020Q1	re	Funds Held Interest Income Expense FundsHeldInterestIncomeExpense	8216000	USD
CY2021Q1	re	Future Policy Benefit Reserve Income Expense FuturePolicyBenefitReserveIncomeExpense	-291000	USD
CY2020Q1	re	Future Policy Benefit Reserve Income Expense FuturePolicyBenefitReserveIncomeExpense	-211000	USD
CY2021Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	273961000	USD
CY2020Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	160122000	USD
CY2021Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	13548000	USD
CY2020Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	12322000	USD
CY2021Q1	us-gaap	Investment Income Net InvestmentIncomeNet	260413000	USD
CY2021Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1882113000	USD
CY2020Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-210588000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	1745000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	7298000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	21774000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	8723000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	21774000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	16398997000	USD
CY2019Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	13611313000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1843691000	USD
CY2019Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1640712000	USD
CY2020Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	14555306000	USD
CY2019Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	11970601000	USD
CY2021Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	1713253000	USD
CY2020Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	1433440000	USD
CY2020Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-2600000	USD
CY2021Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	215302000	USD
CY2021Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	837051000	USD
CY2021Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	1052353000	USD
CY2021Q1	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	-5841000	USD
CY2021Q1	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	15208531000	USD
CY2020Q1	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	12168558000	USD
CY2020Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1651946000	USD
CY2021Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	17090644000	USD
CY2020Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	13820504000	USD
CY2021Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	1713253000	USD
CY2020Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	1433440000	USD
CY2021Q1	re	Public Equity Portfolio Fair Value Disclosure PublicEquityPortfolioFairValueDisclosure	912126000	USD
CY2020Q4	re	Public Equity Portfolio Fair Value Disclosure PublicEquityPortfolioFairValueDisclosure	784746000	USD
CY2021Q1	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1400674000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1472236000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	341862000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	16612000	USD
CY2021Q1	us-gaap	Dividends Common Stock DividendsCommonStock	62229000	USD
CY2020Q1	us-gaap	Dividends Common Stock DividendsCommonStock	63277000	USD
CY2021Q1	us-gaap	Undistributed Earnings UndistributedEarnings	279633000	USD
CY2021Q1	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2020Q1	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	276031000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-46082000	USD
CY2021Q1	re	Dividend Declared Common Shareholders DividendDeclaredCommonShareholders	61415000	USD
CY2020Q1	re	Dividend Declared Common Shareholders DividendDeclaredCommonShareholders	62488000	USD
CY2021Q1	re	Numerator For Basic And Diluted Earnings Per Common Share NumeratorForBasicAndDilutedEarningsPerCommonShare	337446000	USD
CY2020Q1	re	Numerator For Basic And Diluted Earnings Per Common Share NumeratorForBasicAndDilutedEarningsPerCommonShare	16406000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39543000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	40204000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	54000	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	92000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39597000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40296000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39543000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40204000	shares
CY2021Q1	re	Basic Weighted Average Common Shares Outstanding And Nonvested Common Shares Expected To Vest BasicWeightedAverageCommonSharesOutstandingAndNonvestedCommonSharesExpectedToVest	40059000	shares
CY2020Q1	re	Basic Weighted Average Common Shares Outstanding And Nonvested Common Shares Expected To Vest BasicWeightedAverageCommonSharesOutstandingAndNonvestedCommonSharesExpectedToVest	40713000	shares
CY2021Q1	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2020Q1	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-339110000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-334581000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-36678000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1050000000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	52175000	GBP
CY2021Q1	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	376000	USD
CY2020Q1	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	123000	USD
CY2021Q1	re	Federal Home Loan Bank Advances General Debt Obligations Disclosures Maximum Percentage Of Admitted Assets Allowed For Borrowing Base FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumPercentageOfAdmittedAssetsAllowedForBorrowingBase	0.10	pure
CY2021Q1	us-gaap	Security Deposit SecurityDeposit	1293107000	USD
CY2021Q1	us-gaap	Ceded Premiums Written CededPremiumsWritten	99110000	USD
CY2020Q1	us-gaap	Ceded Premiums Written CededPremiumsWritten	110188000	USD
CY2021Q1	re	Ceded Earned Premiums CededEarnedPremiums	78107000	USD
CY2020Q1	re	Ceded Earned Premiums CededEarnedPremiums	90550000	USD
CY2021Q1	re	Ceded Losses And Loss Adjustment Expenses CededLossesAndLossAdjustmentExpenses	80843000	USD
CY2020Q1	re	Ceded Losses And Loss Adjustment Expenses CededLossesAndLossAdjustmentExpenses	45115000	USD
CY2021Q1	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	2476000	USD
CY2020Q1	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	2759000	USD
CY2021Q1	re	Assumed Earned Premiums AssumedEarnedPremiums	2476000	USD
CY2020Q1	re	Assumed Earned Premiums AssumedEarnedPremiums	2759000	USD
CY2021Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	38902000	USD
CY2020Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-210588000	USD
CY2020Q1	re	Corporate Expenses CorporateExpenses	9833000	USD
CY2021Q1	us-gaap	Debt Instrument Redemption Period End Date DebtInstrumentRedemptionPeriodEndDate	2047-05-01
CY2021Q1	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	1462000	USD
CY2020Q1	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	2538000	USD
CY2021Q1	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	45204000	USD
CY2020Q1	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	28592000	USD
CY2020Q1	us-gaap	Net Investment Income NetInvestmentIncome	147800000	USD
CY2021Q1	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	15639000	USD
CY2020Q1	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	7583000	USD
CY2020Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	7990000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-43622000	USD
CY2021Q1	re	Percentage Threshold Of Company Revenue Not Exceeded By Any Other Country PercentageThresholdOfCompanyRevenueNotExceededByAnyOtherCountry	0.05	pure

Files In Submission

Name	View Source	Status
0001095073-21-000017-index-headers.html	Edgar Link	pending
0001095073-21-000017-index.html	Edgar Link	pending
0001095073-21-000017.txt	Edgar Link	pending
0001095073-21-000017-xbrl.zip	Edgar Link	pending
exhibit101.htm	Edgar Link	pending
exhibit101x0x0.gif	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
re-20210331.htm	Edgar Link	pending
re-20210331.xsd	Edgar Link	pending
re-20210331_cal.xml	Edgar Link	unprocessable
re-20210331_def.xml	Edgar Link	unprocessable
re-20210331_htm.xml	Edgar Link	completed
re-20210331_lab.xml	Edgar Link	unprocessable
re-20210331_pre.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EG
EVEREST GROUP, LTD. Stock $eg

2021 Q1 Form 10-Q Financial Statement

#000109507321000017 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EG EVEREST GROUP, LTD. Stock $eg

2021 Q1 Form 10-Q Financial Statement

#000109507321000017 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EG
EVEREST GROUP, LTD. Stock $eg